Latest | Instant Finance & Market News_第196页 | NewTimeSpace

08:21

[ KEYMED BIO-B (02162.HK): Phase II trial of CM512 (TSLP x IL-13 bispecific antibody) for chronic rhinosinusitis with nasal polyps meets all study endpoints; Phase III to advance with 300mg once-half-yearly regimen ] NewTimeSpace News: On 10 August 2026, KEYMED BIO-B (02162.HK): The Phase II clinical trial of self-developed CM512 (TSLP x IL-13 bispecific antibody) for chronic rhinosinusitis with nasal polyps met all study endpoints, with comparable efficacy and a favourable safety profile across dose groups and single-dose efficacy lasting six months; the Company is rapidly initiating Phase III with the 300mg Q24W regimen, and the drug was included in the Breakthrough Therapy Designation list by the CDE of the NMPA on 23 July.

Tag： KEYMED BIO-B 02162.HK R&D Progress

08:18

[ ZHENRO PPT (06158.HK): Proposes restructuring of nine SSE-listed corporate bonds with outstanding principal of approximately RMB 6.661 billion ] NewTimeSpace News: On 10 August 2026, ZHENRO PPT (06158.HK): Indirect wholly-owned subsidiary Zhenro Properties proposes to restructure nine SSE-listed corporate bonds with outstanding principal of approximately RMB 6.661 billion (approximately RMB 7.203 billion including accrued interest); the schemes include a one-off cash payment offsetting 8%, the use of sales proceeds from three property projects and the exchange of remaining principal for new bonds with a maturity of approximately 8.5 years; the restructuring is subject to approval from the majority of bondholders.

Tag： ZHENRO PPT 06158.HK debt restructuring Corporate Bonds

08:13

[ GENFLEET-B (02595.HK): Phase III study of world's first oral KRAS G12D inhibitor for NSCLC initiated; second registrational clinical study of GFH375 completes first patient enrolment ] NewTimeSpace News: On 10 August 2026, GENFLEET-B (02595.HK): The oral KRAS G12D inhibitor GFH375 has entered a registrational Phase III study (the "Qilin-Fei 01") in China as monotherapy for NSCLC, being its second registrational clinical study, with the first patient enrolled at Nanjing Drum Tower Hospital; GFH375 has obtained two BTDs for NSCLC and pancreatic cancer this year, with the latest monotherapy later-line data to be presented as an oral presentation at this year's WCLC.

Tag： GENFLEET-B 02595.HK R&D Progress

08:05

[ SHOUCHENG (00697.HK): Wholly-owned subsidiary participates in investment in Huatai Three Gorges New Energy REIT ] NewTimeSpace News: On 10 August 2026, SHOUCHENG (00697.HK): A company under Shoucheng Jishi, a wholly-owned subsidiary of the Company, participated in an investment in the Huatai Three Gorges New Energy REIT, whose underlying asset is the Zhuanghe III (300MW) offshore wind farm project in Dalian, Liaoning Province, supporting the high-quality development of the clean energy industry and the goals of "carbon peak and carbon neutrality".

Tag： SHOUCHENG 00697.HK Strategic Investment REIT

08:01

[ CHK OIL (00632.HK): Supplementary announcement on termination of executive director's duties, clarifying distinction between termination of service contract and cessation of directorship and the Board's position ] NewTimeSpace News: On 10 August 2026, CHK OIL (00632.HK): The Company published a supplementary announcement on the termination of an executive director's duties, clarifying the distinction between the termination of Ms. Wong's service contract and her cessation as a director and the Board's responses to the disagreements raised in her resignation letter, including prepayments and access to financial information; approximately RMB 55,157,967 and RMB 7,544,659 of trade deposits paid to Longyou and Zhoushan respectively remain unutilised, with the Company actively pursuing recovery.

Tag： CHK OIL 00632.HK Board Change

07:57

[ ZHEJIANG SHIBAO (01057.HK): Proposes private placement of up to 246,789,715 A shares to no more than 35 specific targets, raising up to RMB 1.394 billion ] NewTimeSpace News: On 7 August 2026, ZHEJIANG SHIBAO (01057.HK): The Board approved resolutions for a proposed private placement of up to 246,789,715 A shares to no more than 35 specific targets at the issue price, raising total proceeds of no more than RMB 1.394 billion, mainly for five projects including automotive steer-by-wire steering systems; the issue price will not be lower than 80% of the average trading price over the 20 trading days prior to the pricing date, and the issuance is subject to the review of the Shenzhen Stock Exchange and registration approval of the CSRC.

Tag： ZHEJIANG SHIBAO 01057.HK placement Auto Parts

07:53

[ CHI KINGSTONE (01380.HK): Enters into strategic cooperation MOU with First Asia and First Gold Shop to explore vertical integration along the gold value chain ] NewTimeSpace News: On 10 August 2026, CHI KINGSTONE (01380.HK): The Company entered into a strategic cooperation MOU with First Asia and First Gold Shop on 7 August to explore cooperation along the gold value chain, including gold supply, refining, retail investment, hedging and gold recycling; all cooperation scopes are preliminary and subject to final agreements, with further announcement(s) to be made in due course under the Listing Rules.

Tag： CHI KINGSTONE 01380.HK strategic cooperation Gold

07:45

[ BESUNYEN(00926.HK): 2026 Interim Report - Profit Attributable to Shareholders stood at CNY 15.07 million, YoY increase of 21.48% ] August 07, 2026, BESUNYEN(00926.HK) released its Interim Report for the period ended December 31, 2026, Total Revenue stood at CNY 304.84 million, increased by 17.74% YoY

Tag： BESUNYEN 00926.HK

07:45

[ FIH(02038.HK): 2026 Interim Report - Profit Attributable to Shareholders stood at USD 9.31 million, YoY increase of 50.95% ] August 07, 2026, FIH(02038.HK) released its Interim Report for the period ended December 31, 2026, Total Revenue stood at USD 2.27 billion, increased by 10.14% YoY

Tag： FIH 02038.HK

21:34

[ AUNTEA JENNY (02589.HK): Six Shareholders Voluntarily Extend Lock-Up Commitments to November 7, with Aggregate Reduction Cap of 3,684,228 Shares (Approximately 3.50%) ] NewTimeSpace News: AUNTEA JENNY(02589.HK) voluntarily announced that six shareholders including Suzhou Yizhong have voluntarily undertaken to cap their share reductions during the period from August 7, 2026 to November 7, 2026, with an aggregate cap of no more than 3,684,228 shares (approximately 3.50% of total issued shares); five other shareholders' existing undertakings not to reduce their shareholdings until November 7 remain unchanged.

Tag： AUNTEA JENNY 02589.HK Extend Lock-Up

21:29

[ RUIHE DATA (03680.HK): Establishes RMB 100 Million Venture Capital Fund with Indirect 11.9% Stake, Targeting Emerging Pillar and Future Industries ] NewTimeSpace News: RUIHE DATA(03680.HK) announced that its indirect wholly-owned subsidiary Ruihe Data (Shenzhen) has entered into a partnership agreement with Youshi Financial Holding and Hainan Baoshu to establish a venture capital fund with aggregate committed capital of RMB 100 million (Ruihe Data contributing RMB 11.9 million, or 11.90%), targeting emerging pillar and future industries such as new energy, the low-altitude economy, quantum technology and embodied intelligence; as Youshi Financial Holding is 39.92% owned by non-executive director Mr. Wu Kezhong, the establishment constitutes a connected transaction exempt from independent shareholders' approval.

Tag： RUIHE DATA 03680.HK Partnership Agreement

21:24

[ GRANDPHARMA (00512.HK): Innovative RDC Drug GPN01530-2 Granted FDA Fast Track Designation for Diagnosis of Solid Tumors ] NewTimeSpace News: GRANDPHARMA(00512.HK) announced that GPN01530-2, its self-developed innovative RDC for solid tumor diagnosis, has been granted FDA Fast Track Designation; the drug is a small-molecule FAP-targeting agent that had previously been approved for Phase I/II clinical studies; the global radiopharmaceutical market reached USD 9.7 billion in 2024 and is projected to reach USD 57.3 billion by 2035, while the Group has reserved 16 innovative products in its nuclear medicine segment with six RDCs approved for registered clinical studies.

Tag： GRANDPHARMA 00512.HK R&D Progress

21:19

[ WUXI APPTEC (02359.HK): US Court Grants Preliminary Injunction, Company Shielded from Immediate Adverse Effects While Challenging DoD 1260H Designation ] NewTimeSpace News: WUXI APPTEC (02359.HK) announced that the US District Court for the District of Columbia granted the Company's motion for a preliminary injunction on August 7, 2026, shielding the Company from immediate adverse effects of the DoD's 1260H designation during the judicial proceedings; the Company filed the lawsuit on June 11, 2026, the injunction motion on June 29, 2026, and the hearing was held on July 22, 2026, with the business operating normally.

Tag： WuXi AppTec 02359.HK Litigation

21:14

[ LUZHU BIOTECH-B (02480.HK): Phase III Results of Shingles Vaccine LZ901 Published in Nature Communications, Overall Vaccine Efficacy of 91.6% ] NewTimeSpace News: LUZHU BIOTECH-B (02480.HK) announced that the Phase III results of its core product LZ901 in China were published in Nature Communications: overall vaccine efficacy of 91.6% within one year (95% CI: 86.3%–95.3%), 92.1% against laboratory-confirmed cases and 95.9% against postherpetic neuralgia, with 26,039 subjects enrolled and 25,577 vaccinated; the BLA is currently under review by the NMPA.

Tag： LUZHU BIOTECH-B 02480.HK R&D Progress

20:06

[ HK Stock Connect Weekly Report: Earnings catalysts resonate with policy dividends, "innovative drugs + large models" dual mainlines unfold in HK Stock Connect - 20260807 ] The Hang Seng Index fell 0.84% cumulatively this week, with southbound capital recording a net inflow of approximately HKD 9.9 billion for the full week. The innovative drug sector led the week, catalyzed by BEONE MEDICINES' net profit surging 627% and REMEGEN's first large-scale profitability, with related ETFs sweeping the gainers board; MINIMAX was formally admitted to HK Stock Connect on 6 August, accumulating approximately 28.6% over two days, with Z.AI climbing in tandem and the twin large-model titans performing prominently; CPO and solar sectors also delivered strong performances. In terms of connectivity, the regulators released signals on including REITs in the Shanghai-Shenzhen-Hong Kong Stock Connect, the second phase of HKEX's minimum spread reduction took effect, and a total of four targets including MINIMAX and NEXCHIP were admitted this week.

Tag： HK Stock Connect WuXi AppTec MINIMAX-W LUXSHARE ICT

19:28

[ HK shares Newly Listed Stocks Tracking Weekly Report: Lock-up expiry shock eases, AI concept rebounds; NASN TECH soars 64% on debut day, sentiment in newly listed stocks repairs - 20260807 ] This week, HK newly listed stocks saw more gainers than losers, with NASN TECH up 64% on its debut day and AI concept stocks such as MINIMAX-W and VGT up over 38%; JIANGXI BIO fell 37%. The seven stocks with lock-up expiries performed mildly, with declines such as MUYUAN and EASTROC all within 11%, and the lock-up expiry impact was clearly weaker than last week. QIYUNSHAN FOOD rose 1,147% cumulatively to overtake DEEPZERO at the top, while ZG GROUP-W returned to the biggest drop below its IPO price. Z.AI returned to the top of liquidity with average daily turnover of nearly HKD 7 billion. Next week, AB&B BIO-TECH-B and INNOGEN-B will unlock more than 260 million shares.

Tag： Newly Listed Stocks NASN TECH MINIMAX-W AB&B BIO-TECH-B INNOGEN-B

22:06

[ MIN FU INTL(08511.HK): FY 25/26 Annual Report - Profit Attributable to Shareholders stood at loss of HKD 8.35 million, loss narrowed by 69.45% YoY ] NewTimeSpace News: August 07, 2026, MIN FU INTL(08511.HK) released its Annual Report for the period ended March 31, 2026, Total Revenue stood at HKD 52.89 million, increased by 90.04% YoY

Tag： MIN FU INTL 08511.HK loss narrowed

22:04

[ SUNMI TECH-W (06810.HK): Cornerstone Investor XINWUTANG CO., LIMITED Voluntarily Extends Lock-Up Period by Five Months to March 28, 2027 ] NewTimeSpace News: SUNMI TECH-W (06810.HK) voluntarily announced that cornerstone investor XINWUTANG CO., LIMITED has voluntarily extended the six-month lock-up period by five months to March 28, 2027 (originally ending October 28, 2026); the cornerstone investor holds 9,945,700 H shares, representing approximately 3.33% of issued H shares and approximately 2.47% of total share capital.

Tag： SUNMI TECH-W 06810.HK Extend Lock-Up

21:55

[ CA CULTURAL (01566.HK): Independent Investigation Completed with No Evidence of Fraud or Misappropriation, Reports Adopted, Trading Remains Suspended ] NewTimeSpace News: CA CULTURAL(01566.HK) announced that its independent forensic investigation has been completed and adopted by the Board, with no evidence of fraud or misappropriation by directors or management; the investigation covered 20 events including the consultancy advance payment (HKD 50 million), financial support from Mr. Chong Heung Chung (HKD 81,954,820.82), the ACCP Global subscription default (HKD 215 million) and theme park advance payments (approximately HKD 315 million); no reasonable regulatory concerns over management integrity were identified; the ICAC has concluded its investigation and trading remains suspended.

Tag： CA CULTURAL 01566.HK resumption guidance

21:39

[ JLMAG (06680.HK): Terminates Subscription for Equity in Australian Listed Rare Earth Company Hastings Technology Metals Limited ] NewTimeSpace News: JLMAG (06680.HK) voluntarily announced that, as the conditions precedent to the subscription had not been satisfied, the Company terminated the subscription by its wholly-owned subsidiary JL MAG HK Technology for the equity of Australian listed rare earth company Hastings Technology Metals Limited (originally planned at AUD 0.36 per share for 19.647 million shares, with an aggregate amount of approximately AUD 7.07 million); no payment has been made and the termination will not have a material adverse impact.

Tag： JLMAG 06680.HK Termination of Acquisition

Scan QR Code

Download App